Show simple item record

Nitric oxide (NO) and an NMDA receptor antagonist in pentylenetetrazole-induced convulsions

dc.creatorJelenković, Ankica V.
dc.creatorJovanović, Marina D.
dc.creatorNinković, Milica
dc.creatorMaksimović, Milan
dc.creatorBošković, Bogdan
dc.date.accessioned2015-08-28T10:26:51Z
dc.date.available2015-08-28T10:26:51Z
dc.date.issued2003sr
dc.date.issued2003
dc.identifier.issn0567-8315sr
dc.identifier.otherRad_konverzija_508sr
dc.identifier.urihttps://ibiss-r.rcub.bg.ac.rs/handle/123456789/465
dc.description.abstractControversy about proconvulsant and anticonvulsant nitric oxide (NO) effects and the place of oxidative stress in convulsions, are still a matter of research. We investigated the interaction between 2-amino-5-phosphonovaleric acid (APV), a competitive N-methyl-D-aspartate (NMDA) receptor antagonist and Nw-nitro-L-arginine methyl ester (L-NAME), a nonselective nitric oxide synthase (NOS) antagonist, in pentylenetetrazole (PTZ)-induced convulsions. Pentylenetetrazole was applied to adult Wistar rats intraperitoneally (ip) in a single dose of 80 mg/kg, and L-NAME (10 µg/10 µl) or APV (20 µg/10 µl) intracerebroventricularly (icv), 30 and 10 minutes before PTZ, respectively. In the same manner, another group received both antagonists. Control animals were given 0.9% saline. Nw-nitro-L-arginine methyl ester exerted a weak anticonvulsant effect, preventing generalized clonic (GCC) and clonic-tonic convulsions (CTC) in 17% of cases. With APV protection against GCC and CTC was 100%, forelimb dystonia (FLD) was decreased in 33% of cases, and time to onset of all convulsive patterns was prolonged (p<0.05 to 0.01). All effects of APV, except in CTC, were reversed by L-NAME applied prior to APV. In APV-PTZ treated animals, superoxide anion content was increased in the forebrain cortex, striatum and hippocampus, without an overwhelmed antioxidative superoxide dismutase (SOD) defense system in the other treatments. When the APV-PTZ group was treated with L-NAME, both SOD activity and superoxide anion content were additionally decreased indicating that the NOS-NO system was involved in the metabolism of superoxide anions. It is suggested that clinical and biochemical effects of NO strongly depend upon the pretreatment and might lead to a wrong impression of NO contradictory activity.en
dc.description.abstractKontroverzni nalazi o prokonvulzivnim kao i antikonvulzivnim efektima azot oksida (NO) i značaju oksidativnog stresa u konvulzijama, i dalje su predmet istraživanja. U konvulzijama izazvanim primenom pentilentetrazola (PTZ) ispitivali smo interakciju između 2-amino-5-fosfovalerinske kiseline (APV) kompetitivnog antagoniste N-metil-D-aspartat (NMDA) receptora i Nw-nitro-L-arginin metil estra (L-NAME), neselektivnog antagoniste azot oksid sintaze (NOS). Odraslim pacovima Wistar soja, PTZ je ubrizgavan intraperitonealno (ip) u jednoj dozi od 80 mg/kg. Ostale supstance, L-NAME (10 µg/10 µl) i APV (20 µg/10 µl), primenjivale su se intracerebroventrikularno (icv), i to L-NAME 30, a APV 10 minuta pre PTZ. Po istom vremenskom principu, jedna grupa dobila je oba antagonista, a kontrolna fiziološki rastvor NaCl. Nw-nitro-L-arginin metil estar ispoljio je slabo antikonvulzivno dejstvo, smanjujući incidenciju generalizovanih kloničnih (GCC) i klonično-toničnih konvulzija (CTC) za 17%. Za razliku od L-NAME, APV je sprečila nastanak GCC i CTC kod svih životinja (100%), a incidencija klonusa prednjih nogu (FLD) smanjena je za 33%. Istovremeno primenom APV produženo je vreme od aplikacije PTZ do pojave svih konvulzivnih tipova (p<.05 do 0.01). Primenom L-NAME pre APV, umanjeni su efekti APV, pri čemu je došlo do povećanja incidencije FLD i GCC za 16% odnosno 50%. U kori prednjeg mozga, strijatumu i hipokampusu, životinja koje su dobile APV+PTZ, došlo do povećanja koncentracije superoksidnog anjona. Aktivnost superoksid dizmutaze ne prati ovaj skok. Njen dodatni pad u grupi tretiranoj sa L-NAME pre APV+PTZ, ukazuje da je sistem NOS-NO uključen u metabolizam superoksidnog anjona. Dobijeni rezultati ukazuju da klinički i biohemijski efekti NO u velikoj meri zavise od prethodno primenjenih supstanci i promena izazvanih njima, što može da doprinose sticanju pogrešnog utiska o kontradiktornim dejstvima NO.sr
dc.description.sponsorshipnullsr
dc.language.isoengsr
dc.rightsopenAccesssr
dc.sourceActa veterinariasr
dc.subjectconvulsionsENG
dc.subjectnitric oxideENG
dc.subjectNMDA antagonistsENG
dc.subjectpentylenetetrazoleENG
dc.subjectsuperoxide anionENG
dc.subjectsuperoxide dismutaseENG
dc.titleAzot oksid (NO) i antagonist NMDA receptora u konvulzijama izazvanim pentilenetetrazolomsr
dc.titleNitric oxide (NO) and an NMDA receptor antagonist in pentylenetetrazole-induced convulsionsen
dc.typearticlesr
dc.rights.licenseARR
dcterms.abstractЈеленковић, Aнкица В.; Бошковић, Богдан; Јовановић, Марина Д.; Нинковић, Милица; Максимовић, Милан; Aзот оксид (НО) и антагонист НМДA рецептора у конвулзијама изазваним пентиленететразолом; Aзот оксид (НО) и антагонист НМДA рецептора у конвулзијама изазваним пентиленететразолом;
dc.citation.issue2-3sr
dc.citation.volume53sr
dc.citation.spage103sr
dc.citation.epage112sr
dc.type.versionpublishedVersionsr
dc.identifier.fulltexthttp://ibiss-r.rcub.bg.ac.rs//bitstream/id/2854/Rad_konverzija_508.pdf
dc.citation.rankM23


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record